# Magnesium Sulphate in Perinatal Asphyxia

> **NCT00553072** · PHASE3 · COMPLETED · sponsor: **Sheri Kashmir Institute of Medical Sciences** · enrollment: 40 (actual)

## Conditions studied

- Perinatal Asphyxia , Moderate to Severe HIE

## Interventions

- **DRUG:** Magnesium sulphate
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT00553072
- **Lead sponsor:** Sheri Kashmir Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553072, "Magnesium Sulphate in Perinatal Asphyxia". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00553072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*